China has developed its first single vaccine that prevents both hepatitis A and B. The vaccine to be released into the market costs less than current vaccines for the infectious diseases.

The vaccine to be released into the market costs less than current vaccines for hepatitis A and B.

Research into the vaccine started at the end of 1999. It's hoped the vaccine will narrow China's gap with international hepatitis control and treatment research.

Hepatitis A and B are the major infectious diseases in China and have a negative effect on people's health and social development.

Source: CRIENGLISH.com